Ani

J-K govt downgrades, withdraws security of all 18 Hurriyat leaders, 155 other political persons

ANI | Updated: Feb 21, 2019 00:15 IST

Jammu (Jammu and Kashmir) [India], Feb 20 (ANI): Jammu and Kashmir government on Wednesday downgraded and withdrew the security of 18 Hurriyat leaders.According to the spokesperson of the Home Department, it was felt that providing security to these separatist leaders is wastage of scarce state resources, which could better be utilised elsewhere.Among the leaders whose security has been downgraded and withdrawn are SAS Geelani, Aga Syed Mosvi, Maulvi Abbas Ansari, Yaseen Malik, Saleem Geelani, Shahid ul Islam, Zaffar Akbar Bhat, Nayeem Ahmed Khan, Mukhtar Ahmad Waza, Farooq Ahmed Kichloo, Masroor Abbas Ansari, Aga Syed Abul Hussain, Abdul Gani Shah and Mohd Musadiq Bhat.This is in addition to four separatist leaders whose security was withdrawn on Sunday.In addition, the security of 155 political persons and activists, who did not require the security provided to them based on their threat assessment and their activities, was also withdrawn. This includes Shah Faesal who resigned from the IAS and Wahid Parray.Through this, over 1,000 police personnel and over 100 vehicles are spared to do regular police work. (ANI)   

ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and Year-to-Date 2018 Financial Results

BAUDETTE, Minn., Feb. 20, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ANIP, +0.20% announced today that the Company plans to release its fourth quarter and year-to-date 2018 financial results on Wednesday, February 27, 2019, before the opening of the U.S. financial markets. The earnings press release will be accessible through the Investor Relations section of the Company's website, www.anipharmaceuticals.com.

Arthur S. Przybyl, President and Chief Executive Officer, and Stephen P. Carey, Vice President, Finance, and Chief Financial Officer, also plan to host a conference call to review those results starting at 10:30am Eastern Time on Wednesday, February 27, 2019. The call will be open to the public and can be accessed through a conference line by dialing (866) 776-8875. The conference ID is 4655318.

A recording of the conference call will be available within two hours of the completion of the call and will remain accessible for a period of seven days following the call. To access the replay, dial (800) 585-8367. The access code for the replay is 4655318.

About ANI

ANI Pharmaceuticals, Inc. (the "Company" or "ANI") is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. The Company's targeted areas of product development currently include controlled substances, oncolytics (anti-cancers), hormones and steroids, and complex formulations involving extended release and combination products. For more information, please visit our website www.anipharmaceuticals.com.

For more information about ANI, please contact:

Investor Relations IR@anipharmaceuticals.com

View original content:http://www.prnewswire.com/news-releases/ani-pharmaceuticals-schedules-conference-call-to-discuss-fourth-quarter-and-year-to-date-2018-financial-results-300797496.html

SOURCE ANI Pharmaceuticals, Inc.

Copyright (C) 2019 PR Newswire. All rights reserved

Skating into Winter Break at the Alex and Ani City Center

The Rhode Show Content Disclaimer

The information, advice and answers displayed in The Rhode Show section of WPRI.com are those of individual sponsors and guests and not WPRI-TV/Nexstar Media Group, Inc. WPRI.com presents this content on behalf of each participating Rhode Show sponsor. Sponsored content is copyrighted to its respective sponsor unless otherwise indicated.